Use Code: SAVE26 And Get 30% OFF | Get Free Delivery With No Minimum Order

Frequently bought together
NICOTINELL TTS 30 AID TO SMOKING CESSATIN 7PCS
- Sku : I-004176
Key features
Nicotinell Tts-30 is a transdermal patch containing nicotine 52.5 mg. It delivers nicotine steadily through the skin to help reduce withdrawal symptoms and cravings during smoking cessation. It is used as an aid to treat tobacco and nicotine dependence and support quitting smoking. This OTC pack contains 7 patches.- Brand: Nicotinell
- Active Ingredient: NICOTINE 52.5mg
- Strength: 52.5mg
- Dosage Form: Transdermal patch
- Pack Size: 7 Patches
- Route: Topical
- Prescription Status: OTC
- Therapeutic Class: Nervous System
- Pharmacological Group: Other Nervous System Drugs
- Drug Class: Nicotine replacement therapy (NRT); smoking-cessation pharmacotherapy; nicotinic acetylcholine receptor agonist delivered via transdermal system.
- Manufacturer: LTS LOHMANN Therapie-Systeme
- Country of Origin: Germany
- SFDA Registration No.: 0805233601
- Shelf Life: 36 months
- Storage: do not store above 30°c
- Primary Use: Nicotine replacement therapy to aid smoking cessation and relieve nicotine withdrawal symptoms
Frequently bought together
Indications
Approved Uses
Treatment of tobacco/nicotine dependence as an aid to smoking cessation, to relieve and/or prevent nicotine withdrawal symptoms and reduce cravings.
Pharmacology
Mechanism of Action
Nicotine is a nicotinic acetylcholine receptor agonist; transdermal delivery provides steady systemic nicotine to reduce withdrawal symptoms and cravings during smoking cessation.
Duration of Effect
24 hours per patch.
Product Information
Available Dosage Forms
Transdermal patch, chewing gum, lozenge, inhaler, nasal spray
Composition per Dose
Each patch (30 cm²): 52.5mg nicotine (delivers approximately 21mg nicotine over 24 hours transdermally)
Primary Use
Nicotine replacement therapy to aid smoking cessation and relieve nicotine withdrawal symptoms
Reviewed by Al Mujtama Pharmacy Medical Review Team. Last reviewed 01-07-2026
-1744229570.gif)













